PharmaShots | Incisive News in 3 Shots

Subscribe Now

GSK

GSK Receives the US FDA’s Approval of Ojjaara (momelotinib) for Myelofibrosis Patients with Anemia

GSK Receives the US FDA’s Approval of Ojjaara (momelotinib) for Myelofibrosis Patients with Anemia

September 18, 2023

GSK Reports the MHLW Acceptance of sNDA for Nucala (mepolizumab) in Adults with Chronic Rhinosinusitis with Nasal Polyps

GSK Reports the MHLW Acceptance of sNDA for Nucala (mepolizumab) in Adults with Chronic Rhinosinusitis with Nasal Polyps

September 1, 2023

GSK Reports P-IV Trial (ZOSTER-076) Results of Shingrix (Recombinant Zoster Vaccine) for the Prevention of Shingles in Adults aged ≥50 Years in China

GSK Reports P-IV Trial (ZOSTER-076) Results of Shingrix (Recombinant Zoster Vaccine) for the Prevention of Shingles in Adults aged...

August 23, 2023

GSK’s Jemperli Receives the US FDA Approval as the 1L Treatment for dMMR/MSI-H Primary Advanced or Recurrent Endometrial Cancer

GSK’s Jemperli Receives the US FDA Approval as the 1L Treatment for dMMR/MSI-H Primary Advanced or Recurrent Endometrial Cancer

August 1, 2023

GSK Receives EMA’s CHMP Positive Opinion Recommending Marketing Authorization of Daprodustat for Symptomatic Anaemia Associated with Chronic Kidney Disease

GSK Receives EMA’s CHMP Positive Opinion Recommending Marketing Authorization of Daprodustat for Symptomatic Anaemia Associated wi...

June 26, 2023

GSK Reports P-III Trial (AReSVi-006) Results of Arexvy for Preventing Lower Respiratory Tract Disease Caused by Respiratory Syncytial Virus

GSK Reports P-III Trial (AReSVi-006) Results of Arexvy for Preventing Lower Respiratory Tract Disease Caused by Respiratory Syncyt...

June 22, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us